Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (32) | B (18) | C (20) | D (33) | E (32) | F (11) | G (7) | H (9) | I (21) | K (1) | L (23) | M (12) | N (6) | O (10) | P (26) | R (12) | S (21) | T (26) | U (2) | V (12) | Z (4)
Generic Name Common Trade Name(s)sort icon Classification Date Marketed in Canada (yyyy/mm/dd)
Buprenorphine Sublocade Partial opioid agonist 2019
Zolpidem Sublinox Hypnotic 2011-12-07
Ivermectin Stromectol Anthelmintic 2018/11/07
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil fumarate Stribild Antiretroviral agent 2012/12/20
Regorafenib Stivarga Antineoplastic agent 2013/03/11
Ertugliflozin + sitagliptin Steglujan Oral blood glucose lowering agents 2018/05/22
Ertugliflozin Steglatro Sodium-glucose co-transporter 2 (SGLT2) inhibitor 2018/05/23
Vardenafil Staxyn Phosphodiesterase Type 5 Inhibitor 2011/08/29
Levodopa, carbidopa, entacapone Stalevo Anti-parkinson drugs 2010/08/03
Eculizumab Soliris Humanized monoclonal antibody 2009/06/29
Risankizumab Skyrizi Interleukin-23 inihbitor 2019/05/13
Tedizolid Sivextro Oxazolidinone antibiotic 2015/10/08
Golimumab Simponi Tumor necrosis factor alpha inhibitor (DMARD) 2009/07
Doxepin Silenor Hypnotic 2012/01/08
Pasireotide Signifor Synthetic analogue of somatostatin 2013/11/26
Ertugliflozin + metformin Segluromet Oral blood glucose lowering agents 2018/05/30
Glycopyrronium bromide Seebri Breezhaler Anticholinergic agent 2013/01/29
Ethinyl estradiol + levonorgestrel Seasonique Oral contraceptive 2011/04/15
Liraglutide Saxenda Incretin mimetic 2015/05/27
Asenapine Saphris Atypical antipsychotic 2012/03/16
Tolvaptan Samsca Vasopressin V2 receptor antagonist 2011/09/22
Rupatadine Rupall Antihistamine, second generation 2017/01/25
Ivermectin Rosiver Topical rosacea therapy 2015/05/25
Calcitriol Rocaltrol oral solution Vitamin D analogue
Brexpiprazole Rexulti Antipsychotic agent 2017/04/20
Eltrombopag Revolade Thrombopoietin receptor antagonist 2011/0404
Lenalidomide Revlimid Antineoplastic agent
Sildenafil citrate Revatio IV cGMP-Specific Phosphodiesterase Type 5 Inhibitor 2010/08/31
Cyclosporine Restasis Topical immunomodulator with anti-inflammatory effects 2010/10
Prucalopride Resotran Enterokinetic agent 2012/01/13
Aliskiren and hydrochlorothiazide Rasilez HCT Renin inhibitor and diuretic 2009/09
Silodosin Rapaflo Alpha-1 adrenergic blocker 2012/03/05
Saxagliptin + dapagliflozin Qtern Oral antihyperglycemic agent 2018/03/20
Propofol Propofol Injection Anesthetic, sedative 2010/06/01
Denosumab Prolia RANK Ligand inhibitor 2010/08/10
Buprenorphine Probuphine Opiate partial agonist 2018/04/18
Syndicate content